Page last updated: 2024-10-24

carmustine and (pPNET) Peripheral Primitive Neuroectodermal Tumors

carmustine has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geyer, JR1
Zeltzer, PM1
Boyett, JM1
Rorke, LB1
Stanley, P1
Albright, AL1
Wisoff, JH1
Milstein, JM1
Allen, JC1
Finlay, JL1
Watne, K1
Hager, B1

Other Studies

2 other studies available for carmustine and (pPNET) Peripheral Primitive Neuroectodermal Tumors

ArticleYear
Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cyclophospha

1994
Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
    Journal of neuro-oncology, 1987, Volume: 5, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Female; Humans; Infusio

1987